Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study is conducted in the United States of America (USA). The aim of this study is to assess longitudinal variation of immune biomarkers in subjects with type 1 diabetes (T1D), type 2 diabetes (T2D) and healthy, non-diabetic subjects over a one year period.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
61 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal